Company intelligence / Profile preview

RH2 Equity Partners

New York, New York, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

RH2 Equity Partners is a private equity firm specializing in the lower middle market. While not a biotechnology company developing drugs, it is health-related through its focus on investments in the healthcare services sector, alongside business and industrial services. The firm typically targets companies with $2 million to $10 million in EBITDA, providing capital and operational expertise to founder-led or family-owned businesses.

Industry: Investors

Beyond the preview

Go deeper on RH2 Equity Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RH2 Equity Partners.

Explore the full profile